Molecular Docking Analysis of Eugenol and Paclitaxel Targeting MRAS in Breast Cancer Therapy

سال انتشار: 1403
محل انتشار: چهارمین همایش بین المللی و سیزدهمین همایش ملی بیوانفورماتیک
کد COI اختصاصی: IBIS13_092
زبان مقاله: انگلیسی
تعداد مشاهده: 27

نویسندگان

Department of Genetics, Faculty of Basic Science, Shahrekord University, Shahrekord, Iran

چکیده

Breast cancer is the leading cause of cancer-related deaths among women globally, with its incidence rising worldwide. MRAS, which has unique functions related to classical RAS oncoproteins, is significantly more expressed in estrogen receptor-negative than in estrogen receptor-positive breast carcinomas and is crucial for cell migration and differentiation, influencing cell polarity and prompting research into potential treatments. Eugenol has antioxidant and anti-inflammatory effects, and it can induce apoptosis in cancer cells while inhibiting their migration and viability through specific pathways. Additionally, paclitaxel, a taxane chemotherapy agent, is a vital treatment for breast cancer, disrupting microtubule dynamics to stop cell division and induce apoptosis, significantly improving survival rates and reducing cancer recurrence risk. The aim of this study is to investigate the molecular interactions of eugenol and paclitaxel with the MRAS protein through protein docking, assessing their binding energies. This study will evaluate how these two compounds bind to and block the MRAS protein, which subsequently has inhibitory effects on downstream pathways.

کلیدواژه ها

Breast cancer, MRAS protein, Eugenol, Paclitaxel, Molecular docking, Apoptosis, Cell migration, Chemotherapy

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.